These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 6572047)

  • 1. Immunogenetic studies of juvenile dermatomyositis: HLA-DR antigen frequencies.
    Friedman JM; Pachman LM; Maryjowski ML; Radvany RM; Crowe WE; Hanson V; Levinson JE; Spencer CH
    Arthritis Rheum; 1983 Feb; 26(2):214-6. PubMed ID: 6572047
    [No Abstract]   [Full Text] [Related]  

  • 2. HLA class II alleles in juvenile dermatomyositis.
    Vavrincová P; Havelka S; Cerna M; Stastny P
    J Rheumatol Suppl; 1993 Apr; 37():17-8. PubMed ID: 8501745
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunogenetic studies of juvenile dermatomyositis. HLA antigens in patients and their families.
    Friedman JM; Pachman LM; Maryjowski ML; Jonasson O; Battles ND; Crowe WE; Fink CW; Hanson V; Levinson JE; Spencer CH; Sullivan DB
    Tissue Antigens; 1983 Jan; 21(1):45-9. PubMed ID: 6601315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HLA-D related (DR) antigens in various kinds of myositis.
    Hirsch TJ; Enlow RW; Bias WB; Arnett FC
    Hum Immunol; 1981 Oct; 3(2):181-6. PubMed ID: 6948801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunogenetic risk and protective factors for juvenile dermatomyositis in Caucasians.
    Mamyrova G; O'Hanlon TP; Monroe JB; Carrick DM; Malley JD; Adams S; Reed AM; Shamim EA; James-Newton L; Miller FW; Rider LG;
    Arthritis Rheum; 2006 Dec; 54(12):3979-87. PubMed ID: 17133612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HLA-DR4 in Negro and Mexican rheumatoid arthritis patients.
    Ueno Y; Iwaki Y; Terasaki PI; Park MS; Barnett EV; Chia D; Nakata S
    J Rheumatol; 1981; 8(5):804-7. PubMed ID: 6975826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of HLA class I antigens in skeletal muscle is a diagnostic marker in juvenile dermatomyositis.
    Topaloglu H; Muntoni F; Dubowitz V; Sewry C
    J Child Neurol; 1997 Jan; 12(1):60-3. PubMed ID: 9010797
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C4 complement allotypes in juvenile dermatomyositis.
    Robb SA; Fielder AH; Saunders CE; Davey NJ; Burley MW; Lord DH; Batchelor JR; Dubowitz V
    Hum Immunol; 1988 May; 22(1):31-8. PubMed ID: 3260584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HLA class I and II in black children with hepatitis B virus-associated membranous nephropathy.
    Bhimma R; Hammond MG; Coovadia HM; Adhikari M; Connolly CA
    Kidney Int; 2002 Apr; 61(4):1510-5. PubMed ID: 11918759
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HLA-DR antigens in juvenile chronic arthritis.
    Balogh Z; Gyodi E; Petranyi G; Meretey K; Bozsoky S
    J Rheumatol; 1982; 9(3):448-50. PubMed ID: 6956735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diminished class II-associated Ii peptide binding to the juvenile dermatomyositis HLA-DQ alpha 1*0501/DQ beta 1*0301 molecule.
    Reed AM; Collins EJ; Shock LP; Klapper DG; Frelinger JA
    J Immunol; 1997 Dec; 159(12):6260-5. PubMed ID: 9550430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Different HLA associated gene combinations contribute to susceptibility for coeliac disease and dermatitis herpetiformis.
    Sachs JA; Awad J; McCloskey D; Navarrete C; Festenstein H; Elliot E; Walker-Smith JA; Griffiths CE; Leonard JN; Fry L
    Gut; 1986 May; 27(5):515-20. PubMed ID: 3457750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Penicillamine-induced myositis. Observations and unique features in two patients and review of the literature.
    Halla JT; Fallahi S; Koopman WJ
    Am J Med; 1984 Oct; 77(4):719-22. PubMed ID: 6592972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major histocompatibility complex class I and II detection as a diagnostic tool in idiopathic inflammatory myopathies.
    Jain A; Sharma MC; Sarkar C; Bhatia R; Singh S; Handa R
    Arch Pathol Lab Med; 2007 Jul; 131(7):1070-6. PubMed ID: 17616993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma modulates HLA class II antigen expression on cultured human thymic epithelial cells.
    Berrih S; Arenzana-Seisdedos F; Cohen S; Devos R; Charron D; Virelizier JL
    J Immunol; 1985 Aug; 135(2):1165-71. PubMed ID: 3925000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Schizophrenic disorders and HLA-DR antigens.
    Miyanaga K; Machiyama Y; Juji T
    Biol Psychiatry; 1984 Feb; 19(2):121-9. PubMed ID: 6585231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to a 140-kd protein in juvenile dermatomyositis are associated with calcinosis.
    Gunawardena H; Wedderburn LR; Chinoy H; Betteridge ZE; North J; Ollier WE; Cooper RG; Oddis CV; Ramanan AV; Davidson JE; McHugh NJ;
    Arthritis Rheum; 2009 Jun; 60(6):1807-14. PubMed ID: 19479859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA class II haplotype and autoantibody associations in children with juvenile dermatomyositis and juvenile dermatomyositis-scleroderma overlap.
    Wedderburn LR; McHugh NJ; Chinoy H; Cooper RG; Salway F; Ollier WE; McCann LJ; Varsani H; Dunphy J; North J; Davidson JE;
    Rheumatology (Oxford); 2007 Dec; 46(12):1786-91. PubMed ID: 18003662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenetic studies of juvenile dermatomyositis. III. Study of antibody to organ-specific and nuclear antigens.
    Pachman LM; Friedman JM; Maryjowski-Sweeney ML; Jonnason O; Radvany RM; Sharp GC; Cobb MA; Battles ND; Crowe WE; Fink CW
    Arthritis Rheum; 1985 Feb; 28(2):151-7. PubMed ID: 3871616
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HLA-DR and MT associations with the clinical and serologic manifestations of pauciarticular onset juvenile rheumatoid arthritis.
    Sher MR; Schultz JS; Ragsdale CG; Kapur JJ; Sullivan DB; Cassidy JT
    J Rheumatol; 1985 Feb; 12(1):114-8. PubMed ID: 3872364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.